Last week, the CONQUEST team headed to Argentina to connect with local physicians!
CONQUEST is a global platform clinical trial created by the Scleroderma Research Foundation to accelerate the development of potential new treatments for scleroderma.
During their time in Buenos Aires, the CONQUEST team engaged with dedicated physicians and research staff, offering in-depth training on the study’s design and objectives.
Through its growing network of scleroderma treatment centers worldwide, CONQUEST is advancing critical research efforts focused on improving therapies for people living with for people with systemic sclerosis associated interstitial lung disease (SSc-ILD).
Want to know if you qualify to get involved with CONQUEST? Take the new pre-screener survey. To access the pre-screener, visit the CONQUEST page on the SRF website, and click “Learn More about enrolling in CONQUEST.” From there, click “See if I May Qualify” to take the pre-screener and evaluate CONQUEST as an option for you.
